NASDAQ: ALDX Investor Alert: Lawsuit Alleges Misleading Statements by Aldeyra Therapeutics, Inc.
An investor, who purchased shares of Aldeyra Therapeutics, Inc. (NASDAQ: ALDX), filed a lawsuit over alleged violations of Federal Securities Laws by Aldeyra Therapeutics, Inc.
View full press release